Treatment efficacy of high‐dose creatine supplementation in a child with creatine transporter (SLC6A8) deficiency
Abstract Background Creatine transporter deficiency is an inborn error of metabolism caused by a deficiency in the creatine transporter protein encoded by the SLC6A8 gene. Previous treatment with creatine supplementation, either alone or in combination with creatine precursors (arginine or glycine),...
Main Authors: | Kaili Shi, Huimin Zhao, Shuming Xu, Hong Han, Wenjuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1640 |
Similar Items
-
Creatine transporter deficiency: Novel mutations and functional studies
by: O. Ardon, et al.
Published: (2016-09-01) -
Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring
by: Léa Broca-Brisson, et al.
Published: (2024-04-01) -
Creatine and creatine kinase in health and disease [electronic resource]: /
by: Salomons, Gajja S., et al.
Published: (2007) -
The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome
by: Clemens V. Farr, et al.
Published: (2020-10-01) -
CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport
by: Cheng Tian, et al.
Published: (2023-12-01)